Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06165653 · ClinicalTrials.gov registry record · NA
Guided Meditation During Radiation Therapy for Brain Tumors
A NA study of Brain Neoplasms, sponsored by University of Utah.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06165653: Recruiting NA study of Brain Neoplasms, sponsored by University of Utah.
NCT06165653 is a NA study of Brain Neoplasms that is actively recruiting participants, run by University of Utah. The registered enrollment target is 30 participants, below the 254-participant average among 14 other Brain Neoplasms trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06165653, a NA study of Brain Neoplasms, is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this interventional treatment study is to assess the anxiolytic effect of providing guided meditation during radiation treatment (RT) in patients with brain tumors. The main question it aims to answer is: • What is the change in acute anxiety in participants receiving the mindfulness intervention during radiation therapy compared to standard of care control conditions? Participants will be asked to participate in a 5-minute, audio-recorded mindfulness practice that will be played during the administration of each RT session. Researchers will compare this intervention to standard of care (no intervention) during RT.
Primary Outcome
To assess the acute anxiolytic effects of a brief mindfulness intervention during RT for brain tumor patients with mask anxiety. Acute anxiety during RT will be measured each RT visit with an individual item ("How nervous, anxious or on edge do you feel right now?" scored on a 0-10 scale) derived from the Generalized Anxiety Disorder 2-item (GAD-2) scale, "0" meaning "Not at All" and "10" meaning "Very Much") measured before and after RT. The change from before to after RT will be averaged over
Conditions Studied
Interventions
- BEHAVIORAL 10 to 15-Minute, Audio-Recorded Guided Mediation Practice
Study Locations (1)
Utah
- Huntsman Cancer Institute - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-02-29 |
| Est. Completion | 2028-01-15 |
| Phase | NA |
What NCT06165653 shows while recruiting
NCT06165653 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 254-participant average among 14 other Brain Neoplasms trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Brain Neoplasms appearing as the primary indexed condition, and to 1 intervention - of which 10 to 15-Minute, Audio-Recorded Guided Mediation Practice is the first listed.
NCT06165653 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT06165653 about?
NCT06165653 is a clinical study titled "Guided Meditation During Radiation Therapy for Brain Tumors". The goal of this interventional treatment study is to assess the anxiolytic effect of providing guided meditation during radiation treatment (RT) in patients with brain tumors. The main question it aims to answer is: • What is the change in acute anxiety in participants receiving the mindfulness i...
What is the current status of trial NCT06165653?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-02-29. Estimated completion is 2028-01-15.
What conditions does trial NCT06165653 study?
This clinical trial studies the following conditions: Brain Neoplasms.
What interventions are being tested in trial NCT06165653?
The interventions under investigation include: 10 to 15-Minute, Audio-Recorded Guided Mediation Practice (BEHAVIORAL).
Who is sponsoring clinical trial NCT06165653?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06165653 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06165653's enrollment target sits among peer trials
30 13th of 14 higher than 2 of 14 other Brain Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Brain Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Intraoperative Fluorescence-Guided Aspirate Tissue Monitoring of 5-ALA During Brain Tumor Surgery
RECRUITING · NA
-
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
RECRUITING · NA
-
Ommaya Reservoir Placement at the Time of Biopsy for Longitudinal Biomarker Collection in Patients With Brain Tumors
RECRUITING · NA
-
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
RECRUITING
-
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI